Question 1

Does Los Angeles Capital Management own IOVA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Los Angeles Capital Management holds 43,186 shares of IOVA (Iovance Biotherapeutics), worth $179,653.

Question 2

How many shares of IOVA does Los Angeles Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Los Angeles Capital Management holds 43,186 shares of IOVA (Iovance Biotherapeutics).

Question 3

What is Los Angeles Capital Management's IOVA position worth?

Accepted Answer

As of its Q2 2026 13F, Los Angeles Capital Management's IOVA position is worth $179,653.

Question 4

Is Los Angeles Capital Management buying or selling IOVA?

Accepted Answer

In Q2 2026, Los Angeles Capital Management reduced its IOVA position by 135,973 shares (-75.9%).

Question 5

When did Los Angeles Capital Management first buy IOVA?

Accepted Answer

Los Angeles Capital Management first reported IOVA in its Q1 2019 13F and has listed it in 16 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	43,186	-75.9%	$179,653	0.0%	$4.16	0
2026-Q1	Increased	179,159	+49.5%	$628,848	0.0%	$3.51	34
2025-Q4	Increased	119,860	+381.9%	$233,727	0.0%	$2.73	37
2025-Q3	Decreased	24,871	-34.0%	$53,970	0.0%	$2.17	0
2025-Q2	Increased	37,655	+127.5%	$64,767	0.0%	$1.72	34
2025-Q1	Decreased	16,554	-73.2%	$55,125	0.0%	$3.33	0
2024-Q4	Unchanged	61,759	0.0%	$457,017	0.0%	$7.40	0
2024-Q3	Increased	61,759	+156.0%	$579,917	0.0%	$9.39	39